Bronte Capital Management Pty Ltd.
Sector Allocation
- Financials24.1%$214.2M
- Healthcare16.2%$144.0M
- Technology16.2%$144.0M
- Consumer Staples15.9%$141.0M
- Other12.2%$108.2M
- Consumer Discretionary8.9%$78.7M
- Communication Services3.9%$34.7M
- Materials2.3%$20.5M
- Industrials0.3%$3.0M
AUM History
13fpro.ai/research/fund/bronte-capital-management-pty-ltd-1471085
Conviction and streaks
Stable · top 10 = 74.4%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
GOOGL
$109.1MREGN
$101.4MIBKR
$76.9M- VISA$75.5M
BRK.B
$73.0MAMZN
$62.3MPM
$54.3MCTVA
$38.7MCOF
$34.8MDIS
$34.7MFCNCA
$29.5MTBBB
$22.2MAUR
$14.9M- VANECK$14.5M
SHC
$14.1MNKTR
$13.9MGHC
$13.1M- ISHARES$12.5M
BF-A
$12.4MALNY
$10.7M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/bronte-capital-management-pty-ltd-1471085
Bronte Capital Management Pty Ltd. 13F holdings — Q2 2026
$931.1M portfolio (-7.8% QoQ) · 57 holdings · Q2 2026 13F · top 10 are 74% of the stock portfolio
Includes $42.8M of put/call options ($0 puts, $42.8M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $888.3M. Weights use the stock portfolio.
$109.1M
12.3% of stocks
-20%This quarter-12.8%Since filed10+ qtrsHeld$101.4M
11.4% of stocks
-6%This quarter+5.1%Since filed10+ qtrsHeldAIQuality70.1#220Est. buyEstimated buy price is Pro: unlock with a free trialTrimmed 4 qtrs in a row$76.9M
8.7% of stocks
-31%This quarter-9.2%Since filed10+ qtrsHeld- 4
VISA INC-CLASS A SHARES - COM
$75.5M
8.5% of stocks
-8%This quarter—Since filed—HeldAIQuality—Est. buy— $73.0M
8.2% of stocks
-6%This quarter—Since filed10+ qtrsHeldAIQuality73.5#124Est. buyEstimated buy price is Pro: unlock with a free trialTrimmed 4 qtrs in a row$62.3M
7.0% of stocks
-9%This quarter-8.6%Since filed10+ qtrsHeld$54.3M
6.1% of stocks
-12%This quarter+6.8%Since filed10+ qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialTrimmed 4 qtrs in a row$38.7M
4.3% of stocks
-9%This quarter—Since filed10+ qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialTrimmed 2 qtrs in a row$34.8M
3.9% of stocks
-7%This quarter-8.7%Since filed5 qtrsHeld$34.7M
3.9% of stocks
+94%This quarter+8.5%Since filed2 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 2 qtrs in a row
All holdings — Bronte Capital Management Pty Ltd. (Q2 2026)
57 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | REGENERON PHARMACEUTICALS, INC. | Healthcare | $42.8M | — | 69K | — | — | — | 13F | |
| 12 | FIRST CITIZENS BANCSHARES INC /DE/ | Financials | $29.5M | 3.3% | 14K | -14% | 10+ qtrsTrimmed 4 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | BBB FOODS INC | Consumer Staples | $22.2M | 2.5% | 533K | +9% | 3 qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | Aurora Innovation, Inc. | Technology | $14.9M | 1.7% | 2.19M | -6% | 2 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | — | VANECK ETF TRUST - GOLD MINERS ETFetf/fund | — | $14.5M | 1.6% | 192K | -8% | — | — | 13F |
| 16 | Sotera Health Co | Healthcare | $14.1M | 1.6% | 797K | -6% | 10+ qtrsTrimmed 4 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | NEKTAR THERAPEUTICS | Healthcare | $13.9M | 1.6% | 198K | +0.1% | 2 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | Graham Holdings Co | Consumer Discretionary | $13.1M | 1.5% | 11K | -10% | 10+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | — | ISHARES TR - ISHARES BIOTECHetf/fund | — | $12.5M | 1.4% | 66K | -5% | — | — | 13F |
| 20 | BROWN FORMAN CORP | Consumer Staples | $12.4M | 1.4% | 464K | New | 2 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | ALNYLAM PHARMACEUTICALS, INC. | Healthcare | $10.7M | 1.2% | 35K | -5% | 4 qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | CHEMICAL & MINING CO OF CHILE INCadr | Materials | $8.6M | 1.0% | 116K | -5% | 10+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | Global-E Online Ltd. | Technology | $7.9M | 0.9% | 228K | +7% | 2 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | NEWMONT Corp /DE/ | Materials | $6.5M | 0.7% | 69K | -8% | 5 qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | BARRICK MINING CORP | Materials | $5.4M | 0.6% | 146K | -8% | 5 qtrsTrimmed 4 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $RAMP | LiveRamp Holdings, Inc. | Technology | $4.8M | 0.5% | 128K | -43% | |||
| 27 | $HLF | HERBALIFE LTD. | Consumer Staples | $4.3M | 0.5% | 323K | -66% | |||
| 28 | $RVMD | Revolution Medicines, Inc. | Healthcare | $3.5M | 0.4% | 19K | New | |||
| 29 | $TPB | Turning Point Brands, Inc. | Consumer Staples | $3.5M | 0.4% | 41K | -5% | |||
| 30 | — | ISHARES TR - CORE S&P SCP ETF | — | $3.4M | 0.4% | 23K | New | |||
| 31 | $BBWI | Bath & Body Works, Inc. | Consumer Discretionary | $3.3M | 0.4% | 144K | -8% | |||
| 32 | $MDLZ | Mondelez International, Inc. | Consumer Staples | $3.1M | 0.3% | 53K | -5% | |||
| 33 | $RSKD | RISKIFIED LTD. | Industrials | $3.0M | 0.3% | 588K | +20% | |||
| 34 | $BF-A | BROWN FORMAN CORP | Consumer Staples | $2.6M | 0.3% | 95K | -5% | |||
| 35 | $TYL | TYLER TECHNOLOGIES INC | Technology | $2.4M | 0.3% | 8,302 | New | |||
| 36 | — | VANECK ETF TRUST - JUNIOR GOLD MINE | — | $2.4M | 0.3% | 25K | -8% | |||
| 37 | $PCTY | Paylocity Holding Corp | Technology | $1.9M | 0.2% | 18K | -51% | |||
| 38 | $NICE | NICE Ltd. | Technology | $1.5M | 0.2% | 16K | -4% | |||
| 39 | $OLED | UNIVERSAL DISPLAY CORP \PA\ | Technology | $889K | 0.1% | 10K | -8% | |||
| 40 | $VRSK | Verisk Analytics, Inc. | Technology | $481K | 0.1% | 2,682 | -8% | |||
| 41 | $ENVX | Enovix Corp | Technology | $93K | 0.0% | 42K | +262% | |||
| 42 | $TMCI | TREACE MEDICAL CONCEPTS, INC. | Healthcare | $62K | 0.0% | 16K | New | |||
| 43 | $FATE | FATE THERAPEUTICS INC | Healthcare | $59K | 0.0% | 22K | -5% | |||
| 44 | $ANTX | AN2 Therapeutics, Inc. | Healthcare | $53K | 0.0% | 11K | New | |||
| 45 | $CCCC | C4 Therapeutics, Inc. | Healthcare | $48K | 0.0% | 10K | +3% | |||
| 46 | $ALXO | ALX ONCOLOGY HOLDINGS INC | Healthcare | $37K | 0.0% | 18K | New | |||
| 47 | $BLND | Blend Labs, Inc. | Technology | $33K | 0.0% | 19K | New | |||
| 48 | $PEPG | PepGen Inc. | Healthcare | $32K | 0.0% | 18K | New | |||
| 49 | $CMRC | Commerce.com, Inc. | Technology | $30K | 0.0% | 10K | New | |||
| 50 | $PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Healthcare | $30K | 0.0% | 18K | New | |||
| 51 | $ABOS | Acumen Pharmaceuticals, Inc. | Healthcare | $29K | 0.0% | 11K | New | |||
| 52 | $SEER | Seer, Inc. | Healthcare | $25K | 0.0% | 15K | New | |||
| 53 | $ALEC | Alector, Inc. | Healthcare | $24K | 0.0% | 12K | -39% | |||
| 54 | $NBP | NovaBridge Biosciences | Healthcare | $22K | 0.0% | 11K | New | |||
| 55 | $CHRS | Coherus Oncology, Inc. | Healthcare | $21K | 0.0% | 15K | -21% | |||
| 56 | $MIST | Milestone Pharmaceuticals Inc. | Healthcare | $19K | 0.0% | 14K | +38% | |||
| 57 | $GOSS | Gossamer Bio, Inc. | Healthcare | $11K | 0.0% | 68K | New |
What changed in Q2 2026
Against the previous quarter's 13F: 14 new, 8 added to, 33 trimmed, 11 sold out. Share-count changes; largest moves by dollar size first.
New positions (14)
$RVMDRevolution Medicines, Inc.$3.5M
first bought this quarter
- ISHARES TR - CORE S&P SCP ETF$3.4M
first bought this quarter
$TYLTYLER TECHNOLOGIES INC$2.4M
first bought this quarter
$TMCITREACE MEDICAL CONCEPTS, INC.$62K
first bought this quarter
$ANTXAN2 Therapeutics, Inc.$53K
first bought this quarter
$ALXOALX ONCOLOGY HOLDINGS INC$37K
first bought this quarter
+8 more in the Excel export
Added to (8)
now $34.7M · held 2 qtrs, 2 adds in a row
now $22.2M · held 3 qtrs, 3 adds in a row
$GLBEGlobal-E Online Ltd.+7%
now $7.9M · held 2 qtrs, 2 adds in a row
$RSKDRISKIFIED LTD.+20%
now $3.0M · held 10+ qtrs
$ENVXEnovix Corp+262%
now $93K · held 4 qtrs
now $13.9M · held 2 qtrs
+2 more in the Excel export
Trimmed (33)
now $76.9M · held 10+ qtrs, 7 trims in a row
now $109.1M · held 10+ qtrs, 5 trims in a row
$HLFHERBALIFE LTD.-66%
now $4.3M · held 10+ qtrs, 5 trims in a row
now $54.3M · held 10+ qtrs, 4 trims in a row
- VISA INC-CLASS A SHARES - COM-8%
now $75.5M
now $101.4M · held 10+ qtrs, 4 trims in a row
+27 more in the Excel export
Holdings by quarter
Every 13F Bronte Capital Management Pty Ltd. has filed, 30 earlier quarters. Pick one to see what it held then.
Is it too late to follow Bronte Capital Management Pty Ltd.?
Q2 2026 13F filed with the SEC on Aug 5, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Bronte Capital Management Pty Ltd.'s top 20 holdings: 68/100 (our AI quality score, weighted by position size; 17 of the 20 are scored)
Top 10 since filing
-3.2%
Value-weighted move of the 10 largest stock positions
Turnover
3%
Last quarter; 16% over the last 4
Top 10 weight
74%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
84%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Bronte Capital Management Pty Ltd. disclosed 57 positions worth $931.1M in its Form 13F-HR for Q2 2026 — $888.3M in common stock plus $42.8M of put/call option positions (reported at underlying notional value, not premium at risk), led by $GOOGL (Alphabet Inc.) at 12.3% of the equity portfolio, followed by $REGN and $IBKR. During the quarter the fund opened 14 new positions and exited 11 — including a new stake in $RVMD and a full exit from $NKTR. The portfolio is most concentrated in Financials (24.1% of disclosed assets). All figures are sourced directly from Bronte Capital Management Pty Ltd.’s Form 13F-HR filing with the SEC under CIK 1471085.
Funds like this
managers whose biggest positions overlap Bronte Capital Management Pty Ltd.'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Bronte Capital Management Pty Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For Bronte Capital Management Pty Ltd. (SEC CIK: 1471085), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Bronte Capital Management Pty Ltd.'s portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.